The Effect of Suppression of Adipose Lipolysis on GLP-1 and Energy Intake in Men and Women
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Difference in ad libitum energy intake
研究概览
简要总结
Obesity is the outcome of chronic excessive energy intake and reduced energy expenditure leading to energy imbalance. It is a risk factor for many preventable diseases such as metabolic disease and its consequences such as type 2 diabetes and cardiovascular disease. Sedentary adults have been shown to have an increased appetite in excess of energy requirements and adults who are more active are able to better regulate energy intake. It is thought that carbohydrate availability and specifically hepatic glycogen utilisation during exercise is a regulator of appetite. However, the majority of research so far does not support this theory, potentially due to research not examining the tissue-specific link between glycogen use and appetite. The aim of this study is to assess whether altering substrate utilisation during exercise by suppressing lipolysis influences GLP-1 levels and caloric intake post exercise. Additionally, the study will explore if there is a tissue specific link between substrate utilisation and post exercise energy intake and examine potential sex differences.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Males aged 18-60 and premenopausal women
- •Physically active (at least 30 minutes of exercise 3 times a week)
- •Body mass index 18.0-30.0 kg·m-2
排除标准
- •Weight instability (>5kg change in body mass over last 6 months)
- •Restrained eater (e.g. limiting food intake, calorie counting)
- •Current smoker
- •Aversion or allergy to test meal foods
- •Pregnant or lactating
- •Amenorrhoea in women
- •Any medical condition or medication that could introduce bias into the study (e.g., diabetes, CVD, lipid or glucose metabolism altering medications)
- •Any cardiopulmonary condition prohibiting exercise testing
- •Any contraindication to niacin or aspirin (e.g., diabetes, gout, clotting disorders, allergy to non-steroidal anti-inflammatory drugs)
结局指标
主要结局
Difference in ad libitum energy intake
时间窗: 2 hours post exercise
Difference between ad libitum energy intake (kcal) post exercise between trials
次要结局
未报告次要终点
研究者
Louise Bradshaw
PhD Student
University of Bath
